{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T04:28:29Z","timestamp":1786422509196,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82302134"],"award-info":[{"award-number":["82302134"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science and Technology Projects in Guangzhou","award":["2025A04J4118"],"award-info":[{"award-number":["2025A04J4118"]}]},{"name":"Research Fund of Nanfang Hospital, Southern Medical University","award":["2022B011"],"award-info":[{"award-number":["2022B011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"DOI":"10.1186\/s40644-026-01065-1","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T13:13:22Z","timestamp":1780751602000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Use of contrast-enhanced mammography for preoperative prediction of lymphovascular invasion status in invasive breast cancer"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6145-4704","authenticated-orcid":false,"given":"Liya","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6736-8438","authenticated-orcid":false,"given":"Muzi","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4701-5505","authenticated-orcid":false,"given":"Ying","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3252-2122","authenticated-orcid":false,"given":"Zhiyue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1239-234X","authenticated-orcid":false,"given":"Junyan","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8933-3177","authenticated-orcid":false,"given":"Ziqi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0054-6698","authenticated-orcid":false,"given":"Yanyu","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8567-2708","authenticated-orcid":false,"given":"Xiaomei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"key":"1065_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"1065_CR2","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"1065_CR3","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.2018.19323","volume":"321","author":"AG Waks","year":"2019","unstructured":"Waks AG, Winer EP. Breast Cancer Treatment: A Review. JAMA. 2019;321:288\u2013300.","journal-title":"JAMA"},{"key":"1065_CR4","doi-asserted-by":"crossref","unstructured":"Houvenaeghel G, Cohen M, Classe JM, Reyal F, Mazouni C, Chopin N, et al. Lymphovascular invasion has a significant prognostic impact in patients with early breast cancer, results from a large, national, multicenter, retrospective cohort study. ESMO Open. 2021;6.","DOI":"10.1016\/j.esmoop.2021.100316"},{"key":"1065_CR5","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1159\/000508337","volume":"87","author":"YA Kariri","year":"2020","unstructured":"Kariri YA, Aleskandarany MA, Joseph C, Kurozumi S, Mohammed OJ, Toss MS, et al. Molecular Complexity of Lymphovascular Invasion: The Role of Cell Migration in Breast Cancer as a Prototype. Pathobiology. 2020;87:218\u201331.","journal-title":"Pathobiology"},{"key":"1065_CR6","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12885-022-09193-0","volume":"22","author":"YM Zhong","year":"2022","unstructured":"Zhong YM, Tong F, Shen J. Lympho-vascular invasion impacts the prognosis in breast-conserving surgery: a systematic review and meta-analysis. BMC Cancer. 2022;22:102.","journal-title":"BMC Cancer"},{"key":"1065_CR7","doi-asserted-by":"publisher","first-page":"102923","DOI":"10.1016\/j.esmoop.2024.102923","volume":"9","author":"LW de Boo","year":"2024","unstructured":"de Boo LW, Jozwiak K, Ter Hoeve ND, van Diest PJ, Opdam M, Wang Y, et al. Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naive patients with triple-negative breast cancer. ESMO Open. 2024;9:102923.","journal-title":"ESMO Open"},{"key":"1065_CR8","doi-asserted-by":"publisher","first-page":"3703","DOI":"10.1007\/s00330-020-07502-4","volume":"31","author":"SM Cheung","year":"2021","unstructured":"Cheung SM, Husain E, Mallikourti V, Masannat Y, Heys S, He J. Intra-tumoural lipid composition and lymphovascular invasion in breast cancer via non-invasive magnetic resonance spectroscopy. Eur Radiol. 2021;31:3703\u201311.","journal-title":"Eur Radiol"},{"key":"1065_CR9","doi-asserted-by":"crossref","unstructured":"Kuhn E, Gambini D, Despini L, Asnaghi D, Runza L, Ferrero S. Updates on lymphovascular invasion in breast cancer. Biomedicines. 2023;11.","DOI":"10.3390\/biomedicines11030968"},{"key":"1065_CR10","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.1007\/s00330-021-08504-6","volume":"32","author":"J Zhang","year":"2022","unstructured":"Zhang J, Wang G, Ren J, Yang Z, Li D, Cui Y, et al. Multiparametric MRI-based radiomics nomogram for preoperative prediction of lymphovascular invasion and clinical outcomes in patients with breast invasive ductal carcinoma. Eur Radiol. 2022;32:4079\u201389.","journal-title":"Eur Radiol"},{"issue":"Suppl 1","key":"1065_CR11","doi-asserted-by":"publisher","first-page":"S126","DOI":"10.1016\/j.acra.2021.10.026","volume":"29","author":"Y Kayadibi","year":"2022","unstructured":"Kayadibi Y, Kocak B, Ucar N, Akan YN, Yildirim E, Bektas S. MRI radiomics of breast cancer: machine learning-based prediction of lymphovascular invasion status. Acad Radiol. 2022;29(Suppl 1):S126\u201334.","journal-title":"Acad Radiol"},{"key":"1065_CR12","doi-asserted-by":"crossref","unstructured":"Jiang W, Meng R, Cheng Y, Wang H, Han T, Qu N, et al. Intra- and peritumoral based radiomics for assessment of lymphovascular invasion in invasive breast cancer. J Magn Reson Imaging. 2023.","DOI":"10.1002\/jmri.28776"},{"key":"1065_CR13","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/j.acra.2022.03.011","volume":"29","author":"D Wang","year":"2022","unstructured":"Wang D, Liu M, Zhuang Z, Wu S, Zhou P, Chen X, et al. Radiomics Analysis on Digital Breast Tomosynthesis: Preoperative Evaluation of Lymphovascular Invasion Status in Invasive Breast Cancer. Acad Radiol. 2022;29:1773\u201382.","journal-title":"Acad Radiol"},{"key":"1065_CR14","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/j.acra.2023.11.010","volume":"31","author":"M Xu","year":"2024","unstructured":"Xu M, Yang H, Sun J, Hao H, Li X, Liu G. Development of an Intratumoral and Peritumoral Radiomics Nomogram Using Digital Breast Tomosynthesis for Preoperative Assessment of Lymphovascular Invasion in Invasive Breast Cancer. Acad Radiol. 2024;31:1748\u201361.","journal-title":"Acad Radiol"},{"key":"1065_CR15","doi-asserted-by":"crossref","unstructured":"Xu Z, Xie Y, Wu L, Chen M, Shi Z, Cui Y, et al. Using machine learning methods to assess lymphovascular invasion and survival in breast cancer: performance of combining preoperative clinical and MRI characteristics. J Magn Reson Imaging. 2023.","DOI":"10.1002\/jmri.28647"},{"key":"1065_CR16","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s12885-020-6712-z","volume":"20","author":"Z Liu","year":"2020","unstructured":"Liu Z, Li R, Liang K, Chen J, Chen X, Li X, et al. Value of digital mammography in predicting lymphovascular invasion of breast cancer. BMC Cancer. 2020;20:274.","journal-title":"BMC Cancer"},{"key":"1065_CR17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1148\/radiol.2021201948","volume":"299","author":"MS Jochelson","year":"2021","unstructured":"Jochelson MS, Lobbes MBI. Contrast-enhanced Mammography: State of the Art. Radiology. 2021;299:36\u201348.","journal-title":"Radiology"},{"key":"1065_CR18","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1148\/radiol.210966","volume":"305","author":"G Kim","year":"2022","unstructured":"Kim G, Mehta TS, Brook A, Du LH, Legare K, Phillips J. Enhancement Type at Contrast-enhanced Mammography and Association with Malignancy. Radiology. 2022;305:299\u2013306.","journal-title":"Radiology"},{"key":"1065_CR19","doi-asserted-by":"publisher","first-page":"5439","DOI":"10.1007\/s00330-023-10574-7","volume":"34","author":"S Schiaffino","year":"2024","unstructured":"Schiaffino S, Cozzi A, Clauser P, Giannotti E, Marino MA, van Nijnatten TJA, et al. Current use and future perspectives of contrast-enhanced mammography (CEM): a survey by the European Society of Breast Imaging (EUSOBI). Eur Radiol. 2024;34:5439\u201350.","journal-title":"Eur Radiol"},{"key":"1065_CR20","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1007\/s00330-015-3904-z","volume":"26","author":"Y-C Cheung","year":"2015","unstructured":"Cheung Y-C, Tsai H-P, Lo Y-F, Ueng S-H, Huang P-C, Chen S-C. Clinical utility of dual-energy contrast-enhanced spectral mammography for breast microcalcifications without associated mass: a preliminary analysis. Eur Radiol. 2015;26:1082\u20139.","journal-title":"Eur Radiol"},{"key":"1065_CR21","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1177\/0284185118822639","volume":"60","author":"IPL Houben","year":"2019","unstructured":"Houben IPL, Vanwetswinkel S, Kalia V, Thywissen T, Nelemans PJ, Heuts EM, et al. Contrast-enhanced spectral mammography in the evaluation of breast suspicious calcifications: diagnostic accuracy and impact on surgical management. Acta Radiol. 2019;60:1110\u20137.","journal-title":"Acta Radiol"},{"key":"1065_CR22","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1200\/JCO.19.02309","volume":"38","author":"KH Allison","year":"2020","unstructured":"Allison KH, Hammond MEH, Dowsett M, McKernin SE, Carey LA, Fitzgibbons PL, et al. Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO\/CAP Guideline Update. J Clin Oncol. 2020;38:1346\u201366.","journal-title":"J Clin Oncol"},{"key":"1065_CR23","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","volume":"24","author":"A Goldhirsch","year":"2013","unstructured":"Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Thurlimann B, et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol. 2013;24:2206\u201323.","journal-title":"Ann Oncol"},{"key":"1065_CR24","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.5858\/arpa.2018-0902-SA","volume":"142","author":"AC Wolff","year":"2018","unstructured":"Wolff AC, Hammond MEH, Allison KH, Harvey BE, Mangu PB, Bartlett JMS, et al. Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology\/College of American Pathologists Clinical Practice Guideline Focused Update. Arch Pathol Lab Med. 2018;142:1364\u201382.","journal-title":"Arch Pathol Lab Med"},{"key":"1065_CR25","volume-title":"Contrast-enhanced mammography (CEM) (A supplement to ACR BI-RADS\u00ae Mammography 2013)","author":"H Carol","year":"2022","unstructured":"Carol H, Lee JP, Janice S, Sung JM, Lewin MS, Newell. Contrast-enhanced mammography (CEM) (A supplement to ACR BI-RADS\u00ae Mammography 2013). In. Berlin, Heidelberg: American College of Radiology; 2022."},{"key":"1065_CR26","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo TK, Li MY. A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. J Chiropr Med. 2016;15:155\u201363.","journal-title":"J Chiropr Med"},{"key":"1065_CR27","doi-asserted-by":"publisher","first-page":"5411","DOI":"10.1007\/s00330-023-09513-3","volume":"33","author":"S Zhang","year":"2023","unstructured":"Zhang S, Shao H, Li W, Zhang H, Lin F, Zhang Q, et al. Intra- and peritumoral radiomics for predicting malignant BiRADS category 4 breast lesions on contrast-enhanced spectral mammography: a multicenter study. Eur Radiol. 2023;33:5411\u201322.","journal-title":"Eur Radiol"},{"key":"1065_CR28","doi-asserted-by":"crossref","unstructured":"Ma Q, Li Z, Li W, Chen Q, Liu X, Feng W, et al. MRI radiomics for the preoperative evaluation of lymphovascular invasion in breast cancer: a meta-analysis. Eur J Radiol. 2023;168.","DOI":"10.1016\/j.ejrad.2023.111127"},{"key":"1065_CR29","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41571-021-00560-7","volume":"19","author":"K Bera","year":"2021","unstructured":"Bera K, Braman N, Gupta A, Velcheti V, Madabhushi A. Predicting cancer outcomes with radiomics and artificial intelligence in radiology. Nat Reviews Clin Oncol. 2021;19:132\u201346.","journal-title":"Nat Reviews Clin Oncol"},{"key":"1065_CR30","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.7150\/thno.30309","volume":"9","author":"Z Liu","year":"2019","unstructured":"Liu Z, Wang S, Dong D, Wei J, Fang C, Zhou X, et al. The Applications of Radiomics in Precision Diagnosis and Treatment of Oncology: Opportunities and Challenges. Theranostics. 2019;9:1303\u201322.","journal-title":"Theranostics"},{"key":"1065_CR31","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.cmet.2019.07.015","volume":"30","author":"P Bieniasz-Krzywiec","year":"2019","unstructured":"Bieniasz-Krzywiec P, Mart\u00edn-P\u00e9rez R, Ehling M, Garc\u00eda-Caballero M, Pinioti S, Pretto S, et al. Podoplanin-Expressing Macrophages Promote Lymphangiogenesis and Lymphoinvasion in Breast Cancer. Cell Metabol. 2019;30:917\u2013e936910.","journal-title":"Cell Metabol"},{"key":"1065_CR32","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.18632\/oncotarget.13752","volume":"8","author":"S Zhang","year":"2016","unstructured":"Zhang S, Zhang D, Yi S, Gong M, Lu C, Cai Y, et al. The relationship of lymphatic vessel density, lymphovascular invasion, and lymph node metastasis in breast cancer: a systematic review and meta-analysis. Oncotarget. 2016;8:2863\u201373.","journal-title":"Oncotarget"},{"key":"1065_CR33","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/01.sla.0000133355.48672.22","volume":"240","author":"SF Schoppmann","year":"2004","unstructured":"Schoppmann SF, Bayer G, Aumayr K, Taucher S, Geleff S, Rudas M, et al. Prognostic Value of Lymphangiogenesis and Lymphovascular Invasion in Invasive Breast Cancer. Ann Surg. 2004;240:306\u201312.","journal-title":"Ann Surg"},{"key":"1065_CR34","doi-asserted-by":"crossref","unstructured":"Li J, Mo Y, He B, Gao Q, Luo C, Peng C, et al. Association between MRI background parenchymal enhancement and lymphovascular invasion and estrogen receptor status in invasive breast cancer. Br J Radiol. 2019;92.","DOI":"10.1259\/bjr.20190417"},{"key":"1065_CR35","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s11547-024-01860-5","volume":"129","author":"V Magni","year":"2024","unstructured":"Magni V, Cozzi A, Muscogiuri G, Benedek A, Rossini G, Fanizza M, et al. Background parenchymal enhancement on contrast-enhanced mammography: associations with breast density and patient\u2019s characteristics. Radiol Med. 2024;129:1303\u201312.","journal-title":"Radiol Med"},{"key":"1065_CR36","doi-asserted-by":"publisher","first-page":"W1","DOI":"10.7326\/M14-0698","volume":"162","author":"KG Moons","year":"2015","unstructured":"Moons KG, Altman DG, Reitsma JB, Ioannidis JP, Macaskill P, Steyerberg EW, et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med. 2015;162:W1\u201373.","journal-title":"Ann Intern Med"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40644-026-01065-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-026-01065-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-026-01065-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T03:44:15Z","timestamp":1786419855000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40644-026-01065-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1065"],"URL":"https:\/\/doi.org\/10.1186\/s40644-026-01065-1","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"19 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study was approved by the institutional review board in Nanfang hospital, and the requirement for patient informed consent was waived.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"104"}}